Horizon Pharma, Inc. (HZNP) was a big mover last session, as the company saw its shares rise by roughly 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up almost 28% in the past one-month time frame.
This biotechnology company has seen one positive estimate revision over the last 30 days and its Zacks Consensus Estimate moved higher over the same time frame, suggesting that more solid trading could be ahead for Horizon Pharma. So make sure to keep an eye on this stock going forward to see if this recent move higher can turn into more strength down the road.
Horizon Pharma has a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.
Some better-ranked stocks in the industrial goods sector include Alkermes plc (ALKS), Alexion Pharmaceuticals, Inc. (ALXN) and ANI Pharmaceuticals, Inc. (ANIP). All these stocks hold a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
HORIZON PHARMA INC (HZNP): Free Stock Analysis Report
ALKERMES PLC ORD (ALKS): Free Stock Analysis Report
ALEXION PHARMACEUTICALS INC (ALXN): Free Stock Analysis Report
(ANIP): Free Stock Analysis Report
Zacks Investment Research